Reuters logo
BRIEF-Bionor Pharma Q4 operating loss widens to NOK 31.4 million 
February 12, 2016 / 10:07 AM / 2 years ago

BRIEF-Bionor Pharma Q4 operating loss widens to NOK 31.4 million 

Feb 12 (Reuters) - Bionor Pharma ASA :

* Q4 revenue 15,000 Norwegian crowns versus 130,000 crowns year ago

* Q4 operating loss 31.4 million crowns versus loss 15.1 million crowns year ago

* For FY 2016, expects core cost base to be in range of 58 - 66 million crowns Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below